ATE334680T1 - 4-aminopiperidin-derivate, verfahren zur herstellung und ihre verwendung als arzneimittel - Google Patents

4-aminopiperidin-derivate, verfahren zur herstellung und ihre verwendung als arzneimittel

Info

Publication number
ATE334680T1
ATE334680T1 AT03750658T AT03750658T ATE334680T1 AT E334680 T1 ATE334680 T1 AT E334680T1 AT 03750658 T AT03750658 T AT 03750658T AT 03750658 T AT03750658 T AT 03750658T AT E334680 T1 ATE334680 T1 AT E334680T1
Authority
AT
Austria
Prior art keywords
production
medicinal products
aminopiperidine derivatives
compounds
aminopiperidine
Prior art date
Application number
AT03750658T
Other languages
English (en)
Inventor
Yves Lamberty
Christophe Genicot
Original Assignee
Ucb Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ucb Sa filed Critical Ucb Sa
Application granted granted Critical
Publication of ATE334680T1 publication Critical patent/ATE334680T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56—Nitrogen atoms
    • C07D211/58—Nitrogen atoms attached in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4465—Non condensed piperidines, e.g. piperocaine only substituted in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
AT03750658T 2002-10-04 2003-09-30 4-aminopiperidin-derivate, verfahren zur herstellung und ihre verwendung als arzneimittel ATE334680T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02022191 2002-10-04

Publications (1)

Publication Number Publication Date
ATE334680T1 true ATE334680T1 (de) 2006-08-15

Family

ID=32049973

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03750658T ATE334680T1 (de) 2002-10-04 2003-09-30 4-aminopiperidin-derivate, verfahren zur herstellung und ihre verwendung als arzneimittel

Country Status (21)

Country Link
US (1) US7488741B2 (de)
EP (2) EP1693061A1 (de)
JP (1) JP2006513151A (de)
KR (1) KR20050055748A (de)
CN (1) CN1688307A (de)
AT (1) ATE334680T1 (de)
AU (1) AU2003270291A1 (de)
BR (1) BR0314811A (de)
CA (1) CA2500664A1 (de)
DE (1) DE60307308T2 (de)
DK (1) DK1556045T3 (de)
ES (1) ES2268406T3 (de)
MX (1) MXPA05003290A (de)
NO (1) NO20052172L (de)
NZ (1) NZ539015A (de)
PL (1) PL376368A1 (de)
PT (1) PT1556045E (de)
RU (1) RU2005110409A (de)
SI (1) SI1556045T1 (de)
WO (1) WO2004030668A1 (de)
ZA (1) ZA200502330B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004052858A2 (en) * 2002-12-06 2004-06-24 Eli Lilly And Company Inhibitors of monoamine uptake
US7619096B2 (en) 2003-06-11 2009-11-17 Eli Lilly And Company 3-Aminopyrrolidines as inhibitors of monoamine uptake
WO2005053663A2 (en) * 2003-11-24 2005-06-16 Eli Lilly And Company Norepinephrine reuptake inhibitors useful for treatment of cognitive failure
EP1756050A1 (de) * 2004-06-01 2007-02-28 Eli Lilly And Company Aminomethylazacyclusderivate als inhibitoren der monoaminaufnahme
LT1976828T (lt) 2005-12-29 2017-04-25 Celtaxsys, Inc. Diamino dariniai, kaip leukotrieno a4 hidrolazės inhibitoriai
AU2014249168B2 (en) 2013-03-12 2018-07-12 Celltaxis, Llc Methods of inhibiting leukotriene A4 hydrolase
CA2906035A1 (en) * 2013-03-14 2014-09-25 Celtaxsys, Inc. Inhibitors of leukotriene a4 hydrolase
ES3014615T3 (en) 2018-05-31 2025-04-23 Celltaxis Llc Method of reducing pulmonary exacerbations in respiratory disease patients
CN111233751B (zh) * 2020-03-25 2021-02-02 丽水绿氟科技有限公司 一种3,3-二氟-4-氨基哌啶类化合物及其衍生物的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EG12406A (en) * 1976-08-12 1979-03-31 Janssen Pharmaceutica Nv Process for preparing of novel n-aryl-n-(1-l-4-piperidinyl)-arylacetamides
JPH05148234A (ja) * 1991-10-02 1993-06-15 Hokuriku Seiyaku Co Ltd アルカン酸誘導体
DE4404183A1 (de) * 1994-02-10 1995-08-17 Merck Patent Gmbh 4-Amino-1-piperidylbenzoylguanidine
GB0108876D0 (en) * 2001-04-09 2001-05-30 Novartis Ag Organic Compounds

Also Published As

Publication number Publication date
US7488741B2 (en) 2009-02-10
EP1693061A1 (de) 2006-08-23
CN1688307A (zh) 2005-10-26
PL376368A1 (en) 2005-12-27
NZ539015A (en) 2006-02-24
EP1556045B1 (de) 2006-08-02
NO20052172D0 (no) 2005-05-03
US20060128753A1 (en) 2006-06-15
ZA200502330B (en) 2006-05-31
JP2006513151A (ja) 2006-04-20
RU2005110409A (ru) 2005-09-10
SI1556045T1 (sl) 2007-02-28
PT1556045E (pt) 2006-12-29
AU2003270291A1 (en) 2004-04-23
MXPA05003290A (es) 2005-07-05
ES2268406T3 (es) 2007-03-16
DE60307308T2 (de) 2006-12-28
NO20052172L (no) 2005-06-30
WO2004030668A1 (en) 2004-04-15
BR0314811A (pt) 2005-08-02
CA2500664A1 (en) 2004-04-15
KR20050055748A (ko) 2005-06-13
DK1556045T3 (da) 2006-11-27
EP1556045A1 (de) 2005-07-27
DE60307308D1 (de) 2006-09-14

Similar Documents

Publication Publication Date Title
ATE108453T1 (de) Benzopyridopiperidin, -piperidyliden und - piperazin-verbindungen, zusammensetzungen, methoden zur herstellung und verwendung.
ATE209492T1 (de) Verwendung von 1,2,4-triazolo(1,5-c)pyrimidine heterocyclischen analogen zur herstellung von arzneimitteln zur behandlung von zerebrovascularen störungen
BR0309167A (pt) Composto, processo para a produção de um composto, composição farmacêutica, uso do composto, método para o tratamento de um sujeito afetado por uma condição patológica ou doença e produto de combinação
EA200602191A1 (ru) 5,5-дизамещённые-2-амино-4-тиазолидиноны и способ их получения, фармацевтическая композиция и способ лечения
WO2004009549A3 (en) Piperidines useful for the treatment of central nervous system disorders
NO178262C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive substituerte cykloheksanoler
DE10337184A1 (de) Substituierte 3-Pyrrolidin-Indol-Derivate
FR2723091B1 (fr) Tetrahydropyridine-(6,4-hydroxypiperidine) alkylazoles
WO2005023815A3 (en) Neuroprotective bicyclic compounds and methods for their use
ATE401304T1 (de) Kationisch substituierte diphenylazetidinone, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
EP1784388B8 (de) Biphenyloxyessigsäure - derivate zur behandlung von atemwegserkränkungen
CY1110711T1 (el) Παραγωγα πυραζολο [3,4-d]αζεπινης ως ανταγωνιστες ισταμινης η3
CA2498291A1 (en) Diazabicyclic compounds useful in the treatment of cns and other disorders
DE60221283D1 (de) Verwendung von oxindolderivaten zur behandlung von mit demenz in zusammenhang stehenden krankheiten, alzheimer-krankheit und mit glycogensynthasekinase-3 assoziierten leiden
HUP0003078A2 (hu) 5-HT3 és 5-HT4 receptorok által közvetített betegségek kezelésére alkalmazható (+)-norciszaprid
ATE334680T1 (de) 4-aminopiperidin-derivate, verfahren zur herstellung und ihre verwendung als arzneimittel
ATE247645T1 (de) Neue piperazinylalkylthiopyrimidine derivate, diese enthaltende pharmazeutische zusammenstellungen und verfahren zu deren herstellung
DE50311923D1 (de) Harnstoff- und urethan-substituierte acylharnstoffe, verfahren zu deren herstellung und deren verwendung als arzneimittel
ATE442355T1 (de) Herstellung von 4,5-dialkyl-3-acylpyrrol-2- carbonsäurederivaten durch synthese nach fischer- fink und anschliebende acylierung
WO2005055943A3 (en) Vinorelbine derivatives
ATE435864T1 (de) Substituierte 5,6,7,8-tetrahydro-imidazoä1 ,2- aüpyridin-2-ylamin-verbindungen und deren verwendung zur herstellung von arzneimitteln
DE60041137D1 (de) Ceramid ähnliche verbindungen, verfahren zu deren herstellung und deren verwendung als antitumormittel
ATE421961T1 (de) Piperidinderivate, verfahren zu deren herstellung und pharmazeutische zusammensetzung zur behandlung von alzheimer-krankheit, die diese derivate enthält
DE60136544D1 (de) Verfahren und zwischenprodukte zur herstellung von pyrrolidinen
DE69724418D1 (de) Heterocyclische verbindungen und ihre herstellung und verwendung

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1556045

Country of ref document: EP

REN Ceased due to non-payment of the annual fee